Published in Clin Auton Res on August 01, 2004
Autonomic neuropathy in hemodialysis patients: questionnaires versus clinical tests. Clin Exp Nephrol (2009) 0.82
Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. BMC Nephrol (2015) 0.81
QT Interval and QT Dispersion in Patients Undergoing Hemodialysis: Revisiting the Old Theory. Nephron Extra (2011) 0.77
QT-interval parameters in end-stage renal disease--is cardiovascular autonomic neuropathy unimportant? Clin Auton Res (2004) 0.75
There is No Association between Cardiovascular Autonomic Dysfunction and Peripheral Neuropathy in Chronic Hemodialysis Patients. J Clin Neurol (2010) 0.75
The effects of different electrolyte composition in dialysate on QTc interval; a controlled trial. J Renal Inj Prev (2016) 0.75
Association of Corrected QT and QT Dispersion with Echocardiographic and Laboratory Findings in Uremic Patients under Chronic Hemodialysis. J Cardiovasc Echogr (2017) 0.75
QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation (1991) 4.37
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant (2002) 1.96
Effect of hemodialysis on the dispersion of the QTc interval. Nephron (1998) 1.57
Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia (1991) 1.52
QT interval dispersion in chronic heart failure and left ventricular hypertrophy: relation to autonomic nervous system and Holter tape abnormalities. Br Heart J (1994) 1.14
The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia (1999) 1.11
QT dispersion before and after hemodialysis. J Am Soc Nephrol (1999) 1.10
QTc dispersion increases during hemodialysis with low-calcium dialysate. Kidney Int (2000) 0.99
QT dispersion in patients with end-stage renal failure and during hemodialysis. J Am Soc Nephrol (1999) 0.97
Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant (1994) 0.91
Potassium removal increases the QTc interval dispersion during hemodialysis. Nephron (1999) 0.89
Dynamic QT interval analysis in uraemic patients receiving chronic haemodialysis. J Hypertens (2003) 0.87
Diseases and drugs causing prolongation of the QT interval. Am J Cardiol (1987) 0.86
ECG changes and cardiac arrhythmias in chronic renal failure patients on hemodialysis. J Electrocardiol (1992) 0.84
Cough test to assess cardiovascular autonomic reflexes in diabetes. Diabetes Care (1990) 0.83
QT interval prolongation in the patients receiving maintenance hemodialysis. Clin Nephrol (1998) 0.82
Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia (1996) 0.82
Measurement and interpretation of QT dispersion. Prog Cardiovasc Dis (2000) 0.79
Increased QT interval dispersion after hemodialysis: role of peridialytic electrolyte gradients. Angiology (2000) 0.78
An automated computerized method using Finapres for measuring cardiovascular reflexes. Clin Sci (Lond) (1992) 0.75
Impact of hemodialysis on QT interval. Acta Cardiol (1995) 0.75
Cardiac repolarization interval in end-stage diabetic and nondiabetic renal disease. Clin Cardiol (1997) 0.75
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology (2002) 3.29
Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients. Kidney Int (2004) 1.78
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant (2012) 1.48
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy. Diabetes (2011) 1.08
Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study. Diabetes Care (2003) 0.98
Factors increasing the risk for stone formation in adult patients with cystic fibrosis. Nephrol Dial Transplant (2006) 0.97
QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. Diabetes Care (2011) 0.95
Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care (2007) 0.94
Fine-needle aspiration biopsy of the thyroid: comparison between thyroid palpation and ultrasonography. Endocr Pract (2002) 0.94
Patients on renal replacement therapy for 20 or more years: a clinical profile. Nephrol Dial Transplant (2002) 0.92
Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis (2005) 0.92
N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study. Diabetes Care (2013) 0.91
Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway. Am J Pathol (2008) 0.88
Prevention and treatment of nonalcoholic fatty liver disease. Dig Liver Dis (2010) 0.87
Primary hyperoxaluria: genotype-phenotype correlation. J Nephrol (2003) 0.87
Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study. Diabetes Care (2005) 0.86
Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP. J Neurol (2002) 0.86
Patient referral is influenced by dialysis centre structure in the Diamant Alpin Dialysis cohort study. Nephrol Dial Transplant (2004) 0.85
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. Nephrol Dial Transplant (2012) 0.85
Dermatan sulfate: an alternative to unfractionated heparin for anticoagulation in hemodialysis patients. J Nephrol (2013) 0.84
Electrophysiological findings of peripheral neuropathy in newly diagnosed type II diabetes mellitus. J Peripher Nerv Syst (2005) 0.83
Yeast haspin kinase regulates polarity cues necessary for mitotic spindle positioning and is required to tolerate mitotic arrest. Dev Cell (2013) 0.83
Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient. Transpl Int (2009) 0.83
Cost analysis of blood purification in intensive care units: continuous versus intermittent hemodiafiltration. J Nephrol (2003) 0.82
Helicobacter pylori infection and gastric function in primary autonomic neuropathy. Clin Auton Res (2002) 0.81
Vascular access survival and morbidity on daily dialysis: a comparative analysis of home and limited care haemodialysis. Nephrol Dial Transplant (2004) 0.81
Dialysis choice in the context of an early referral policy: there is room for self care. J Nephrol (2005) 0.80
Does carvedilol impair insulin sensitivity in heart failure patients without diabetes? J Card Fail (2005) 0.79
Low-protein vegetarian diet with alpha-chetoanalogues prior to pre-emptive pancreas-kidney transplantation. Rev Diabet Stud (2004) 0.79
Dabigatran overdose: case report of laboratory coagulation parameters and hemodialysis of an 85-year-old man. Blood Coagul Fibrinolysis (2015) 0.78
Mechanical determinants of early acute ventilatory failure in COPD patients: a physiologic study. Intensive Care Med (2008) 0.77
Levels of N-terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case-cohort analysis of the population-based Casale Monferrato study. Diabetes Metab Res Rev (2014) 0.76
[Adherence to therapy in patients on hemodialysis]. G Ital Nefrol (2011) 0.76
Think of oxalate when using ascorbate supplementation to optimize iron therapy in dialysis patients. Nephrol Dial Transplant (2007) 0.76
CYP11B2 -344T/C gene polymorphism and blood pressure in patients with acromegaly. J Clin Endocrinol Metab (2006) 0.76
Effects of dermatan sulfate for anticoagulation in continuous renal replacement therapy. J Nephrol (2008) 0.75
Correspondence between the International Diabetes Federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic Caucasians: the GISIR database. Diabetes Care (2007) 0.75
Biochemical evaluation in renal stone disease. Clin Cases Miner Bone Metab (2008) 0.75
Protective effect of vitamin C supplementation in dialysis patients: not all that glitters... Kidney Int (2005) 0.75
Metformin-Associated Lactic Acidosis Undergoing Renal Replacement Therapy in Intensive Care Units: A Five-Million Population-Based Study in the North-West of Italy. Blood Purif (2017) 0.75
[The effects of Cinacalcet in renal stone formers with primary hyperparathyroidism]. G Ital Nefrol (2016) 0.75
[Diagnostic and therapeutic approach in patients with urinary calculi]. G Ital Nefrol (2010) 0.75
Computer program to prescribe acetate-free biofiltration as a continuous renal replacement therapy: theoretical description and in vivo validation. J Nephrol (2006) 0.75
Dialysate/infusate calcium and magnesium. Contrib Nephrol (2002) 0.75
Reversibile quadriplegia and nonketotic hyperosmolar coma: is it an exceptional association or an overlooked complication? Diabetes Care (2004) 0.75
Clinical and electrophysiological correlations in type 2 diabetes mellitus at diagnosis. Diabetes Res Clin Pract (2006) 0.75
[The Hyperoxalurias]. G Ital Nefrol (2016) 0.75
Severe course of primary hyperoxaluria and renal failure after domino hepatic transplantation. Am J Transplant (2005) 0.75
Autonomic function and autoantibodies to autonomic nervous tissues at follow-up in a cohort of young patients with type 1 diabetes. Effects of serum from diabetic patients on human adrenergic cells. J Neuroimmunol (2003) 0.75
Introductory remarks. J Nephrol (2011) 0.75
[Genetic approach to nephrolithiasis]. G Ital Nefrol (2015) 0.75
LDL electronegativity is enhanced in type 1 diabetes. Diabetes Care (2003) 0.75
[The effects of continuous renal replacement therapy (CRRT) and intermittent haemodialysis (IHD) in the treatment of dabigatran overdose. Case report]. G Ital Nefrol (2014) 0.75